|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 477.10 USD | -0.95% |
|
+0.85% | +5.24% |
| Market Cap | 122B 106B 98.71B 90.7B 171B 11,661B 174B 1,163B 456B 5,808B 459B 449B 19,243B | P/E 2026 * |
27.5x | P/E 2027 * | 24.3x |
|---|---|---|---|---|---|
| Enterprise Value | 109B 94.13B 87.61B 80.5B 152B 10,350B 155B 1,033B 405B 5,155B 407B 399B 17,080B | EV / Sales 2026 * |
8.31x | EV / Sales 2027 * | 7.22x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.95% | ||
| 1 week | +0.85% | ||
| Current month | -3.95% | ||
| 1 month | -3.95% | ||
| 3 months | +11.63% | ||
| 6 months | +1.53% | ||
| Current year | +5.24% |
| 1 week | 469.87 |  | 493.61 |
| 1 month | 465 | | 533.67 |
| Current year | 412.27 | | 533.67 |
| 1 year | 362.5 | | 533.67 |
| 3 years | 340.2 | | 533.67 |
| 5 years | 176.36 | | 533.67 |
| 10 years | 71.46 | | 533.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 2019-04-09 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/21/26 | Free | General Counsel | 8,251 | 0.0033% | ||
| 7/21/26 | Free | Public Communications Manager | 8,251 | 0.0033% | ||
| 7/15/26 | Free | Director | 100 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | +0.85% | +1.69% | +34.75% | 122B | |
| -0.53% | -3.12% | +51.15% | +150.58% | 1,030B | |
| +0.21% | -1.13% | +53.26% | +46.92% | 617B | |
| -2.51% | -2.33% | +32.56% | +66.35% | 455B | |
| +0.06% | +1.17% | +36.21% | +31.25% | 350B | |
| -0.14% | -0.83% | +33.24% | +40.28% | 299B | |
| -0.69% | -0.44% | +9.86% | +14.23% | 265B | |
| -7.37% | -4.31% | -5.69% | -41.99% | 225B | |
| -0.64% | +3.68% | +27.80% | +62.95% | 209B | |
| -0.82% | -0.50% | +13.46% | +69.41% | 163B | |
| Average | -1.16% | +4.52% | +25.35% | +47.47% | 373.49B | |
| Weighted average by Cap. | -0.65% | +4.77% | +35.47% | +69.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.05B 11.32B 10.54B 9.68B 18.3B 1,245B 18.59B 124B 48.74B 620B 49.01B 47.94B 2,054B | 14.36B 12.46B 11.59B 10.65B 20.13B 1,369B 20.45B 137B 53.61B 682B 53.92B 52.74B 2,260B |
| Net income | 4.51B 3.91B 3.64B 3.34B 6.32B 430B 6.42B 42.91B 16.83B 214B 16.93B 16.56B 710B | 5.12B 4.44B 4.14B 3.8B 7.18B 489B 7.3B 48.77B 19.13B 243B 19.24B 18.82B 807B |
| Net Debt | -13.74B -11.92B -11.1B -10.2B -19.27B -1,311B -19.58B -131B -51.32B -653B -51.62B -50.48B -2,163B | -18.62B -16.15B -15.03B -13.81B -26.1B -1,776B -26.52B -177B -69.51B -884B -69.91B -68.38B -2,930B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | $477.10 | -0.95% | 947,762 |
| 26-07-30 | $481.70 | -0.34% | 1,249,350 |
| 26-07-29 | $483.33 | -1.44% | 1,451,920 |
| 26-07-28 | $490.39 | +2.38% | 1,700,871 |
| 26-07-27 | $479.00 | +0.34% | 1,631,004 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
